Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord-derived mesenchymal stem cells (SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi)
- Development stage
- Unknown
- Lead developer
- Sağlık Bilimleri Üniversitesi Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
This investigational cell therapy consists of allogenic umbilical cord-derived mesenchymal stem cells (UC-MSCs) produced under GMP conditions by Bakirkoy Dr. Sadi Konuk Training and Research Hospital (SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi) in collaboration with Istinye University. The therapy is designed to treat severe COVID-19 and associated pneumonia by modulating the hyperinflammatory immune response and controlling the cytokine storm characteristic of critically ill patients. Administered intravenously in three doses (on days 0, 3, and 6), these stem cells leverage their immunomodulatory and regenerative properties to repair lung damage and improve clinical outcomes in intensive care settings. The treatment aims to reduce mortality by mitigating the systemic inflammatory response and promoting tissue recovery.
- Other names
- UC-MSCsAllogenic umbilical cord-derived mesenchymal stem cellsMesenchymal Stem Cell Therapy (SBÜ Dr. Sadi Konuk)
Beyond the preview
Go deeper on umbilical cord-derived mesenchymal stem cells (SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord-derived mesenchymal stem cells (SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi).